Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Hypertension (htn) Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

6 recruiting trials for Hypertension (htn). Eligibility criteria explained in plain English.

TrialFinderData lists 6 Hypertension (htn) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by University of Thessaly (1), Mohamed Mohamed Ali Morgan (1), Necmettin Erbakan University (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Dietary supplement intervention Goodphyte IB Defense (dietary_supplement, 1 trial), followed by Dietary supplement intervention Goodphyte Immunity, Transcutaneous Electrical Nerve Stimulation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
0
Phase 3 Trials
6
Sponsors

Track Hypertension (htn) trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07380022

Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB...

The primary objective of the present postdoctoral research is to evaluate the acceptability and adherence of two dietary supplements containing microbial phytase, Goodphyte IB...

Sponsor: University of ThessalyEnrolling: 1001 location
RECRUITINGNCT07383220

Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure

The goal of this clinical trial is to learn if the combination between transcutaneous electrical nerve stimulation (TENS) and isometric exercise (IE) can improve blood pressure in...

Sponsor: Mohamed Mohamed Ali MorganEnrolling: 501 location
RECRUITINGNCT07480265

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

This prospective single-center observational study aims to evaluate the relationship between elevated plasma homocysteine levels and early echocardiographic abnormalities in...

Sponsor: Necmettin Erbakan UniversityEnrolling: 5001 location
RECRUITINGNCT07232017

Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic

The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed...

Sponsor: Anita Misra-HebertEnrolling: 15201 location
RECRUITINGNCT07240831

Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring...

This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard...

Sponsor: Biobeat Technologies Ltd.Enrolling: 60010 locations
RECRUITINGNCT07583940

Low Energy Availability and Hypertension in Division I HBCU Athletes

Low energy availability (LEA) occurs when the body does not get enough calories to support both daily life and exercise. This can happen when athletes train hard but do not eat...

Sponsor: North Carolina Agriculture & Technical State UniversityEnrolling: 1501 location

Frequently Asked Questions

There are currently 6 clinical trials for Hypertension (htn), with 6 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Hypertension (htn), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Hypertension (htn), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.